Description

Melbek (meloxicam) tablets 15 mg. №30

Ingredients

Active ingredient: Meloxicam 15 mg per tablet.

Dosage

Dosage: The usual dose is 15 mg taken once daily. Consult your healthcare provider for the correct dosage for your condition.

Indications

Indications: Meloxicam is used to relieve pain and inflammation in conditions such as osteoarthritis and rheumatoid arthritis.

Contraindications

Contraindications: Do not use Melbek if you have a history of allergic reactions to meloxicam or other NSAIDs.

Directions

Directions: Take Melbek exactly as prescribed by your doctor. Do not exceed the recommended dose.

Scientific Evidence

Meloxicam, the active ingredient in Melbek tablets, is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the enzymes responsible for inflammation. Studies have shown that meloxicam is effective in reducing pain and inflammation associated with various arthritic conditions. Research published in the journal *Arthritis Research & Therapy* demonstrated the efficacy of meloxicam in improving joint function and reducing pain in patients with osteoarthritis.

Additional Information

Meloxicam, the key component of Melbek tablets, has a longer half-life compared to other NSAIDs, allowing for once-daily dosing. This can improve patient compliance and convenience. It is important to note that NSAIDs like meloxicam may increase the risk of cardiovascular events and gastrointestinal complications, especially with long-term use. Consult your healthcare provider for personalized advice.

Pharmacological Effects: Meloxicam inhibits the enzyme cyclooxygenase, thereby reducing the production of prostaglandins that cause pain and inflammation. This mechanism of action distinguishes it from other NSAIDs, offering a more targeted approach to managing arthritic conditions.

Clinical Trials: Clinical trials have shown that meloxicam is as effective as other NSAIDs in providing pain relief with potentially fewer gastrointestinal side effects. A study published in *The Journal of Rheumatology* compared the efficacy of meloxicam with diclofenac in patients with osteoarthritis and found similar pain reduction and functional improvement between the two drugs.